Lawrence Eichenfield, MD

Lawrence Eichenfield, MD, Chief, Pediatric and Adolescent Dermatology,

Rady Children‘s Hospital-San Diego

Articles by Lawrence Eichenfield, MD

Lebrikizumab phase 3 data show improvements in atopic dermatitis symptoms, itch in children

ByLawrence Eichenfield, MD,Contemporary Pediatrics Staff

August 24th 2026

Phase 3 data show lebrikizumab improved skin clearance, itch, and quality of life in children with moderate-to-severe atopic dermatitis.

Lawrence Eichenfield, MD, discusses roflumilast success in pediatric atopic dermatitis

ByLawrence Eichenfield, MD

March 16th 2026

The INTEGUMENT-OLE study results highlight the long-term efficacy and safety of roflumilast cream for pediatric patients with atopic dermatitis.

Lawrence Eichenfield, MD, Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics

Lawrence Eichenfield, MD; and Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis

ByLawrence Eichenfield, MD,Rocco Serrao, MD

October 7th 2025

A pair of roflumilast clinical trial investigators react to the FDA approval of the 0.05% formulation to treat atopic dermatitis in children aged 2 to 5 years.

Lawrence Eichenfield, MD

Articles by Lawrence Eichenfield, MD

Lebrikizumab phase 3 data show improvements in atopic dermatitis symptoms, itch in children

Lawrence Eichenfield, MD, discusses roflumilast success in pediatric atopic dermatitis

Lawrence Eichenfield, MD; and Rocco Serrao, MD, react to roflumilast approval for pediatric atopic dermatitis

Latest Updated Articles

Trending on Contemporary Pediatrics

Abbott launches first ready-to-feed whole milk infant formula in the U.S.

FDA news in pediatrics: August 2026

Bifidobacteria Decline: Causes and Consequences for Infant Gut Health

The unharmonious 2026 child and adolescent immunization schedule

Can you guess the diagnosis of this teenaged girl with flat-topped papules?